2024 annual financial data
Voyager Therapeutics 2024 Operating margin
Voyager Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -104.11%.
Operating income was -83,287,000 USD and net income was -65,002,000 USD.
Operating cash flow was -15,310,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 80,001,000 USD
- Operating income
- -83,287,000 USD
- Net income
- -65,002,000 USD
- Operating cash flow
- -15,310,000 USD